Shuyu Tang1, Wenwen Jiang1,2, Hsin-Yu Chen1,2, Robert Bok1, Daniel B Vigneron1,2, Peder E Z Larson1,2. 1. Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California, USA. 2. UC Berkeley-UCSF Graduate Program in Bioengineering, University of California, San Francisco and University of California, Berkeley, USA.
Abstract
PURPOSE: A novel application of two-dimensional (2D) spatially selective radiofrequency (2DRF) excitation pulses in hyperpolarized 13C imaging is proposed for monitoring the bolus injection with highly efficient sampling of the initially polarized substrate, thus leaving more polarization available for detection of the subsequently generated metabolic products. METHODS: A 2DRF pulse was designed with a spiral trajectory and conventional clinical gradient performance. To demonstrate the ability of our 2DRF bolus tracking pulse sequence, hyperpolarized [1-(13)ruvate in vivo imaging experiments were performed in normal rats, with a comparison to 1DRF excitation pulses. RESULTS: Our designed 2DRF pulse was able to rapidly and efficiently monitor the injected bolus dynamics in vivo, with an 8-fold enhanced time resolution in comparison with 1DRF in our experimental settings. When applied at the pyruvate frequency for bolus tracking, our 2DRF pulse demonstrated reduced saturation of the hyperpolarization for the substrate and metabolic products compared to a 1DRF pulse, while being immune to ±0.5 ppm magnetic field inhomogeneity at 3T. CONCLUSION: 2DRF pulses in hyperpolarized 13C imaging can be used to efficiently monitor the bolus injection with reduced hyperpolarization saturation compared to 1DRF pulses. The parameters of our design are based on clinical scanner limits, which allows for rapid translation to human studies.
PURPOSE: A novel application of two-dimensional (2D) spatially selective radiofrequency (2DRF) excitation pulses in hyperpolarized 13C imaging is proposed for monitoring the bolus injection with highly efficient sampling of the initially polarized substrate, thus leaving more polarization available for detection of the subsequently generated metabolic products. METHODS: A 2DRF pulse was designed with a spiral trajectory and conventional clinical gradient performance. To demonstrate the ability of our 2DRF bolus tracking pulse sequence, hyperpolarized [1-(13)ruvate in vivo imaging experiments were performed in normal rats, with a comparison to 1DRF excitation pulses. RESULTS: Our designed 2DRF pulse was able to rapidly and efficiently monitor the injected bolus dynamics in vivo, with an 8-fold enhanced time resolution in comparison with 1DRF in our experimental settings. When applied at the pyruvate frequency for bolus tracking, our 2DRF pulse demonstrated reduced saturation of the hyperpolarization for the substrate and metabolic products compared to a 1DRF pulse, while being immune to ±0.5 ppm magnetic field inhomogeneity at 3T. CONCLUSION: 2DRF pulses in hyperpolarized 13C imaging can be used to efficiently monitor the bolus injection with reduced hyperpolarization saturation compared to 1DRF pulses. The parameters of our design are based on clinical scanner limits, which allows for rapid translation to human studies.
Authors: John Kurhanewicz; Daniel B Vigneron; Kevin Brindle; Eduard Y Chekmenev; Arnaud Comment; Charles H Cunningham; Ralph J Deberardinis; Gary G Green; Martin O Leach; Sunder S Rajan; Rahim R Rizi; Brian D Ross; Warren S Warren; Craig R Malloy Journal: Neoplasia Date: 2011-02 Impact factor: 5.715
Authors: Mads S Vinding; Christoffer Laustsen; Ivan I Maximov; Lise Vejby Søgaard; Jan H Ardenkjaer-Larsen; Niels Chr Nielsen Journal: J Magn Reson Date: 2012-12-13 Impact factor: 2.229
Authors: E Johansson; S Månsson; R Wirestam; J Svensson; J S Petersson; K Golman; F Ståhlberg Journal: Magn Reson Med Date: 2004-03 Impact factor: 4.668
Authors: Y-F Yen; S J Kohler; A P Chen; J Tropp; R Bok; J Wolber; M J Albers; K A Gram; M L Zierhut; I Park; V Zhang; S Hu; S J Nelson; D B Vigneron; J Kurhanewicz; H A A M Dirven; R E Hurd Journal: Magn Reson Med Date: 2009-07 Impact factor: 4.668
Authors: Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron; Peder E Z Larson; Andrea L Harzstark; Marcus Ferrone; Mark van Criekinge; Jose W Chang; Robert Bok; Ilwoo Park; Galen Reed; Lucas Carvajal; Eric J Small; Pamela Munster; Vivian K Weinberg; Jan Henrik Ardenkjaer-Larsen; Albert P Chen; Ralph E Hurd; Liv-Ingrid Odegardstuen; Fraser J Robb; James Tropp; Jonathan A Murray Journal: Sci Transl Med Date: 2013-08-14 Impact factor: 17.956
Authors: S M Kazan; S Reynolds; A Kennerley; E Wholey; J E Bluff; J Berwick; V J Cunningham; M N Paley; G M Tozer Journal: Magn Reson Med Date: 2012-11-20 Impact factor: 4.668
Authors: Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron Journal: Radiology Date: 2019-03-05 Impact factor: 11.105